ReviewEndocrine-related cancer2026

Molecular determinants of AR-enhancer interaction and cistrome reprogramming in prostate cancer progression.

Rayzel C Fernandes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.